A Highly Anticipated Selective Therapeutic Agent against CDK2: INX-315. | Colorado PROFILES

Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)

Menu

History

A Highly Anticipated S

Cytochrome b6f Complex

Depression symptoms an

Ear

See All (4) pages

Contact Us
If you have any questions or feedback please contact us.

A Highly Anticipated Selective Therapeutic Agent against CDK2: INX-315.

Watts LP, Spencer SL. A Highly Anticipated Selective Therapeutic Agent against CDK2: INX-315. Cancer Discov. 2024 Mar 01; 14(3):386-388.

View in: PubMed

subject areas

authors with profiles

Sabrina Leigh Spencer

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)